SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indo Biotech Foods Ltd (519222)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 519222 NSE: Consumer Food | Small Cap | Indo Biotech Foods Share Price

BSE Share Price
Not Listed

Indo Biotech Foods Ltd (519222)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 519222 NSE: Consumer Food | Small Cap | Indo Biotech Foods Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹9 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹-0
TTM Sales
₹0 Cr.
Book Value per Share
₹10
P/E Ratio
0.00
Industry PE
55.5
Price to Book (P/B)
0.40
Price to Sales (P/S)
0.00
EV/EBITDA
-188.34
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
0.00%
Return on Capital Employed (ROCE)
0.00%
Return on Assets (ROA)
-3928.90%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
-
-
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
55.49%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹22.1 Cr.
Face Value
₹10
All Time Low / High
₹0.25 / 42.50

Indo Biotech Foods stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Sep'08Sep'09Sep'10Sep'11Sep'12Sep'13Sep'14Mar'15Mar'16Mar'17TTM
ROCE % -3.3%373.1%-1.1%2.8%-10.9%-5.4%-5.7%-0.8%-356.5%0%-

Growth Parameters

Sales 00000000000
Sales YoY Gr.-NANANANANANANANANA-
Adj EPS -01.4-00-0-0-00-0.3-0-0
YoY Gr.-NA-100%NA-300%NANANANANA-
BVPS (₹) -2.5-1.1-1.1-1.1-1.1-1.1-1.1-2.3-1.4-1.410
Adj Net
Profit
-03.1-00-0-0-0-0-0.6-0.1-0
Cash Flow from Ops. -02.5-0-0.1-0-0-0-0-0-0-
Debt/CF from Ops. -219.81.2-531.2-62.8-433.7-314.9-633.8-671.7-1146.9-715-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NANANANA
Adj EPS NANANANA
BVPSNANANANA
Share Price - - - -

Key Financial Parameters

Sep'08Sep'09Sep'10Sep'11Sep'12Sep'13Sep'14Mar'15Mar'16Mar'17TTM
Return on
Equity %
0.6-77.60.3-0.71.611.10.120.72-0.7
Op. Profit
Mgn %
-4260.2-75717.8-667.9-2442.3-2189.2-1336.4-2160.5-809.9-168202.80NAN
Net Profit
Mgn %
-4635.1497094.5-1005.11735.5-2797.7-1387.1-2225.2-888.2-168202.80-INF
Debt to
Equity
-1.2-1.3-1.3-1.2-1.2-1.2-1.2-1.2-1-0.9-
Working Cap
Days
43,32941,93927,25110,7720000000
Cash Conv.
Cycle
-30,521-3,12,28127,14910,7270000000

Profit And Loss

(All Figures are in Crores.)
PARTICULARSSep'08Sep'09Sep'10Sep'11Sep'12Sep'13Sep'14Mar'15Mar'16Mar'17
Sales0000000000
Operating Expenses + 0.030.470.010.020.030.030.0300.580.06
Manufacturing Costs0000000000
Material Costs0000000000
Employee Cost 0.030000.010.010000.01
Other Costs 00.4700.020.030.020.0300.580.05
Operating Profit -0.03-0.47-0-0.02-0.03-0.02-0.03-0-0.58-0.06
Operating Profit Margin (%) -4,260.2%-75,717.8%-667.0%-2,442.3%-2,189.2%-1,336.4%-2,160.5%-809.0%-1,68,202.8%-
Other Income + 03.5200.04000000
Exceptional Items 0000-0.0200000
Interest 0000000000
Depreciation 0000000000
Profit Before Tax -0.033.06-0.010.02-0.06-0.03-0.03-0-0.58-0.06
Tax 0000000000
Profit After Tax -0.033.06-0.010.02-0.06-0.03-0.03-0-0.58-0.06
PAT Margin (%) -4,635.1%4,97,094.5%-1,005.1%1,735.5%-4,031.0%-1,387.1%-2,225.2%-888.0%-1,68,202.8%-
Adjusted EPS (₹)-0.01.40.00.0-0.0-0.0-0.00.0-0.3-0.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Valuation of Indo Biotech Foods - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSSep'08Sep'09Sep'10Sep'11Sep'12Sep'13Sep'14Mar'15Mar'16Mar'17

Equity and Liabilities

Shareholders Fund + -5.47-2.41-2.42-2.40-2.46-2.49-2.51-2.52-3.09-3.16
Share Capital 22.0822.0822.0822.0822.0822.0822.0822.0822.0822.08
Reserves -27.55-24.49-24.50-24.49-24.54-24.57-24.59-24.60-25.18-25.24
Debt +6.503.023.032.942.952.962.962.972.972.97
Long Term Debt6.503.023.032.942.952.962.962.972.972.97
Short Term Debt0000000000
Minority Interest0000000000
Trade Payables2.64000000000
Others Liabilities 0.01000.010.060.070.090.090.130.19
Total Liabilities 3.680.610.610.550.550.550.550.5400

Fixed Assets

Net Fixed Assets +3.520.550.550.550.550.540.540.5400
Gross Block9.870.750.750.750.750.750.750.7500
Accumulated Depreciation6.360.200.200.200.210.210.210.2100
CWIP 0000000000
Investments 0.05000000000
Inventories00.050.050000000
Trade Receivables0000000000
Cash Equivalents 0.020.0100000000
Others Assets 0.09000000000
Total Assets 3.680.610.610.550.550.550.550.5400

Cash Flow

(All Figures are in Crores.)
PARTICULARSSep'08Sep'09Sep'10Sep'11Sep'12Sep'13Sep'14Mar'15Mar'16Mar'17
Cash Flow From Operating Activity + -0.032.50-0.01-0.05-0.01-0.01-0-0-0-0
PBT -0.030.01-0.010.02-0.06-0.03-0.03-0-0.58-0.06
Adjustment 00.470000000.540
Changes in Working Capital 02.020-0.060.050.020.02-00.030.06
Tax Paid 0000000000
Cash Flow From Investing Activity + 0-2.5000000000
Capex 0-2.5000000000
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity + 0.03-000.040.010.010000
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0.03000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others -0-000.040.010.010000
Net Cash Flow -0-0.01-0-0-000-00-0

Financial Ratio

PARTICULARSSep'08Sep'09Sep'10Sep'11Sep'12Sep'13Sep'14Mar'15Mar'16Mar'17
Ratios
ROE (%)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
ROCE (%)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Asset Turnover Ratio0000000000
PAT to CFO Conversion(x)N/A0.82N/A-2.5N/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days0000000000
Inventory Days0000000000
Payable Days00740.90334.20000000

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Indo Biotech Foods Ltd FAQs

The current trading price of Indo Biotech Foods on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Indo Biotech Foods stood at ₹8.83 Cr

The latest P/E ratio of Indo Biotech Foods as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Indo Biotech Foods as of 31-Dec-1969 is 0.40.

The 52-week high of Indo Biotech Foods is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Indo Biotech Foods is ₹0.00 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Indo Biotech Foods Ltd

No data to display
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×